Home > Compound List > Product Information
(Ethoxycarbonylmethyl)triphenylphosphonium bromide_Molecular_structure_CAS_1530-45-6)
Click picture or here to close

(Ethoxycarbonylmethyl)triphenylphosphonium bromide

Catalog No. 412252 Name Sigma Aldrich
CAS Number 1530-45-6 Website http://www.sigmaaldrich.com
M. F. C22H22BrO2P Telephone 1-800-521-8956
M. W. 429.286641 Fax
Purity 98% Email
Storage Chembase ID: 74861

SYNONYMS

Title
乙氧甲酰基甲基三苯基溴化膦
IUPAC name
(2-ethoxy-2-oxoethyl)triphenylphosphanium bromide
IUPAC Traditional name
(2-ethoxy-2-oxoethyl)triphenylphosphanium bromide
Synonyms
(Carboxymethyl)triphenylphosphonium bromide ethyl ester
NSC 60450

DATABASE IDS

PubChem SID 24865798
EC Number 216-230-1
Beilstein Number 3581273
MDL Number MFCD00011835
CAS Number 1530-45-6

PROPERTIES

Linear Formula CH3CH2OCOCH2P(C6H5)3Br
Purity 98%
Melting Point 145-150 °C (dec.)(lit.)
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
RTECS TA2299500
Safety Statements 26-36
German water hazard class 3

DETAILS

Description (English)
Packaging
100 g in poly bottle
Application
Reactant for:
• Wittig olefination reactions for synthesis of tetramic acid derivatives1
• Synthesis of precursors for Bergman cyclization2
• Preparation of PPAR agonists derived from thalidomide-related LXR antagonists3
• Synthesis of benzoxaboroles with antimalarial activity4
• Michael acceptor based cysteine protease inhibitors5
• Mechanistic studies of the IspH reductase protein6
Description (简体中文)
包装
100 g in poly bottle
Application
Reactant for:
• Wittig olefination reactions for synthesis of tetramic acid derivatives1
• Synthesis of precursors for Bergman cyclization2
• Preparation of PPAR agonists derived from thalidomide-related LXR antagonists3
• Synthesis of benzoxaboroles with antimalarial activity4
• Michael acceptor based cysteine protease inhibitors5
• Mechanistic studies of the IspH reductase protein6

REFERENCES